NanoSphere Health Sciences Wins Trio of ACQ5 Global Awards 2018
CEO Robert Sutton Recognized as Gamechanger of the Year; NanoSphere Named Company of the Year for Nano-Biotechnology and Innovative Company of the Year for Healthcare
DENVER (August 21, 2018) – NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the nano-biotechnology company that has commercialized a patented delivery system known as the NanoSphere Delivery System™, has won three 2018 Global Awards from ACQ5, a premier global corporate magazine.
NanoSphere Health Sciences Partners with Delta 9 for Canadian Expansion
Dear Valued Shareholders,
Since our last update in April 2018, we have seen significant milestones for NanoSphere Health Sciences. We began the second quarter by announcing new licensing agreements to expand our Evolve Formulas brand into California and Arizona, followed by winning a prestigious award for technological innovation from Frost & Sullivan and retaining Gravitas Securities Inc as financial advisors.
NanoSphere Health Sciences Secures Patent For Groundbreaking Nanoparticle Delivery of Cannabis
Biotech Leader’s Cannabis Division, Evolve Formulas, Prepares to Launch in Canadian Market
DENVER (July 31, 2018)- NanoSphere Health Sciences, INC (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, has entered into a partnership with Delta 9 Cannabis INC to bring products from its cannabis brand, Evolve Formulas, into the Canadian market.
Statement from NanoSphere Health Sciences and Evolve Formulas CEO and Chairman Robert Sutton
Denver (July 24, 2018) -- NanoSphere Health Sciences LLC (CSE: NSHS) (OTC: NSHSF) has been awarded a breakthrough patent, granting the biotech innovator full ownership over the standardized delivery of cannabis into systemic circulation through phospholipid nanoparticle technology. The United States Patent and Trademark Office has issued US Patent No. 10,028,919 today, covering NanoSphere Health Sciences’ cannabinoid drug delivery system
NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen
Statement from NanoSphere Health Sciences and Evolve Formulas CEO and Chairman Robert Sutton regarding the proposed regulation of marijuana nasal sprays, inhalers and suppositories in Colorado by the Marijuana Enforcement Division and Colorado Department of Public Health and Environment.
NanoSphere Health Sciences’ Brand Evolve Formulas Expanding Rapidly Across Colorado and Beyond
New Campaign Aims to Educate Athletes on Marijuana Healing Potential
DENVER (July 16, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the biotech firm behind the groundbreaking NanoSphere Delivery System™, has announced that its cannabis brand Evolve Formulas will partner with Jeff Friesen, former NHL player and marijuana advocate, in a campaign to educate athletes about the benefits of cannabis as a natural health supplement.
NanoSphere Health Sciences To Report Revenue and Sees Significant Sales Growth in Second Quarter
Next-Generation Cannabis Products Now Available in Over 200 Colorado Dispensaries, with Production Beginning in the California Market
NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the biotech firm behind the groundbreaking NanoSphere Delivery System™, is experiencing a period of rapid growth for its cannabis brand, Evolve Formulas. The company has not only successfully expanded the product line to over 200 dispensaries in the Colorado market, but has also officially begun training and preparation for production in the California market.
Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team
Biotech leader increases cannabis brand sales in Colorado by 30 percent ahead of California launch
DENVER (July 4, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the biotech firm behind the cutting-edge patented NanoSphere Delivery System™ and the cannabis brand Evolve Formulas, today reports solid growth for this year’s second quarter.
NanoSphere spearheads delivery of medical nano-encapsulated THC/CBD
Renowned Advocate and Scientist Takes on Medical Advisor Role for Evolve Formulas
DENVER, June 7, 2018 /PRNewswire/ -- Dr. Michele Ross, neuroscientist, author and cannabinoid medicine leader, has joined the advisory board for NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF), the biotechnology leader behind the patented NanoSphere Delivery System™, which nano-encapsulates cannabinoid molecules in lipid membranes for transportation through the skin into the bloodstream within minutes.
NanoSphere Health Sciences Retains Gravitas Securities and Grant Options
NanoSphere Health Sciences (CSE:NSHS; OTC:NSHSF) has developed a newly-patented delivery technology that increases the bioavailability and bioactivity of its Evolve line of gel-like cannabinoids for the treatment of pain, inflammation and anxiety.
NanoSphere Health Sciences Wins Prestigious Frost & Sullivan 2018 Technology Innovation Award
Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has retained the services of Gravitas Securities Inc. (“Gravitas”) to act as financial advisors to the company. NanoSphere also wishes to announce that it has granted 3,165,555 options to directors, officers and consultants of the company at a price of $0.65.
NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California
Nano-Biotechnology Firm Recognized for its Next-Generation Medical Delivery System in the Frost & Sullivan 2018 Best Practices Awards
DENVER (May 23, 2018) – NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), the nano-biotechnology company that has commercialized a patented delivery system known as the NanoSphere Delivery System™, has been awarded the 2018 Technology Innovation Award by Frost & Sullivan as part of the annual Best Practices Awards for North America. These awards recognize excellence across a number of fields and are the result of independent research conducted by Frost & Sullivan, which specializes in business growth partnerships.
Cannabis Breakthrough: Precise Cannabinoid Delivery
Licensing agreement will bring the patented NanoSphere Delivery System™ to the world’s largest legal market this summer
DENVER (May 2, 2018)– NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, has joined forces with Vertical™, the largest fully integrated company in the legal medical cannabis industry, to launch Evolve’s growing product line in Arizona and California this summer.
NanoSphere's Evolve Formulas Releases CBD Version of Game-Changing NanoSerum™
Any marketing guru will tell you that the most successful products are those that precisely meet the user’s needs while making as little fuss as possible. This has been a major issue in the cannabis market since day one because drug delivery methods were developed during an era of prohibition, forcing users to set fire to plants and inhale them in dark corners; hardly
Are Transdermals the Future of Cannabis?
New product formula utilizes CBD, THC and resveratrol for rapid repair and rejuvenation with nanotechnology for the ultimate therapy
DENVER, April 30, 2018 /PRNewswire/ -- NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), parent company of cannabis brand Evolve Formulas, today announced the latest addition to its cannabis product line-up using NanoSphere Health's patented delivery technology. The new Transdermal NanoSerum™ CBD pen is now available with a desirable 10:1 ratio of CBD:THC. The product will be in Colorado dispensaries starting in mid-May.
Letter from Our Chairman
Dr. Richard Kaufman makes some thoughtful arguments about the speed of transdermal delivery.
NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform
Dear Valued Shareholders,
I would like to take this opportunity to outline the details of a significant milestone for NanoSphere Health Sciences and how this will impact the future of the company. We have been granted our landmark patent for the NanoSphere Delivery System™, which means we now officially have ownership of the biggest advancement in non-invasive medical delivery in over 25 years. A major thank you is in order to everyone who has come on this journey with us, especially those who have been here since the very beginning—from the challenging years of R&D through the pivotal point of commercialization to now, as we realize this new reality and lay the foundation for the bright future of this business.
Nano-Technology Brings Precision to Cannabis
Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery system
Denver (March 27, 2018) – NanoSphere Health Sciences Inc (CSE: NSHS) (OTC: NSHSF) is pleased to announce that its flagship subsidiary, NanoSphere Health Sciences, LLC, has been granted Patent No. 9,925.149—which covers the core technology behind the production of the NanoSphere Delivery System™—by the United States Patent and Trademark Office.
CFN Media Exclusive Interview with NanoSphere Health Sciences President and COO Mr. David Sutton
CannabisTech had the opportunity to speak with David Sutton, the President and Chief Operating Officer of NanoSphere Health Sciences about their new product Evolve Nanoserum and the technology which made it possible.
CFN sat down with NanoSphere Health Sciences COO David Sutton at the recent Seed to Sale show in Denver Colorado.
As research into cannabis has grown, the demand for new and innovative delivery methods has exploded. NanoSphere Health Sciences (NSHS.CN) (CSE:NSHS) (CNSX: NSHS) is disrupting the space through its innovative delivery systems,